Literature DB >> 21226578

Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

Amit V Khera1, Marina Cuchel, Margarita de la Llera-Moya, Amrith Rodrigues, Megan F Burke, Kashif Jafri, Benjamin C French, Julie A Phillips, Megan L Mucksavage, Robert L Wilensky, Emile R Mohler, George H Rothblat, Daniel J Rader.   

Abstract

BACKGROUND: High-density lipoprotein (HDL) may provide cardiovascular protection by promoting reverse cholesterol transport from macrophages. We hypothesized that the capacity of HDL to accept cholesterol from macrophages would serve as a predictor of atherosclerotic burden.
METHODS: We measured cholesterol efflux capacity in 203 healthy volunteers who underwent assessment of carotid artery intima-media thickness, 442 patients with angiographically confirmed coronary artery disease, and 351 patients without such angiographically confirmed disease. We quantified efflux capacity by using a validated ex vivo system that involved incubation of macrophages with apolipoprotein B-depleted serum from the study participants.
RESULTS: The levels of HDL cholesterol and apolipoprotein A-I were significant determinants of cholesterol efflux capacity but accounted for less than 40% of the observed variation. An inverse relationship was noted between efflux capacity and carotid intima-media thickness both before and after adjustment for the HDL cholesterol level. Furthermore, efflux capacity was a strong inverse predictor of coronary disease status (adjusted odds ratio for coronary disease per 1-SD increase in efflux capacity, 0.70; 95% confidence interval [CI], 0.59 to 0.83; P<0.001). This relationship was attenuated, but remained significant, after additional adjustment for the HDL cholesterol level (odds ratio per 1-SD increase, 0.75; 95% CI, 0.63 to 0.90; P=0.002) or apolipoprotein A-I level (odds ratio per 1-SD increase, 0.74; 95% CI, 0.61 to 0.89; P=0.002). Additional studies showed enhanced efflux capacity in patients with the metabolic syndrome and low HDL cholesterol levels who were treated with pioglitazone, but not in patients with hypercholesterolemia who were treated with statins.
CONCLUSIONS: Cholesterol efflux capacity from macrophages, a metric of HDL function, has a strong inverse association with both carotid intima-media thickness and the likelihood of angiographic coronary artery disease, independently of the HDL cholesterol level. (Funded by the National Heart, Lung, and Blood Institute and others.).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21226578      PMCID: PMC3030449          DOI: 10.1056/NEJMoa1001689

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  38 in total

1.  Cellular cholesterol efflux to serum is impaired in diabetic nephropathy.

Authors:  Huali Zhou; Kathryn C B Tan; Sammy W M Shiu; Ying Wong
Journal:  Diabetes Metab Res Rev       Date:  2008 Nov-Dec       Impact factor: 4.876

Review 2.  Future therapeutic directions in reverse cholesterol transport.

Authors:  Amit V Khera; Daniel J Rader
Journal:  Curr Atheroscler Rep       Date:  2010-01       Impact factor: 5.113

3.  The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages.

Authors:  Margarita de la Llera-Moya; Denise Drazul-Schrader; Bela F Asztalos; Marina Cuchel; Daniel J Rader; George H Rothblat
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-01-14       Impact factor: 8.311

4.  ABCG1 and HDL protect against endothelial dysfunction in mice fed a high-cholesterol diet.

Authors:  Naoki Terasaka; Shuiqing Yu; Laurent Yvan-Charvet; Nan Wang; Nino Mzhavia; Read Langlois; Tamara Pagler; Rong Li; Carrie L Welch; Ira J Goldberg; Alan R Tall
Journal:  J Clin Invest       Date:  2008-10-16       Impact factor: 14.808

Review 5.  Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins.

Authors:  A R Tall
Journal:  J Intern Med       Date:  2008-03       Impact factor: 8.989

6.  The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans.

Authors:  Bonnie Ky; Anne Burke; Sotirios Tsimikas; Megan L Wolfe; Mahlet G Tadesse; Philippe O Szapary; Joseph L Witztum; Garret A FitzGerald; Daniel J Rader
Journal:  J Am Coll Cardiol       Date:  2008-04-29       Impact factor: 24.094

Review 7.  Update on strategies to increase HDL quantity and function.

Authors:  Danielle Duffy; Daniel J Rader
Journal:  Nat Rev Cardiol       Date:  2009-06-02       Impact factor: 32.419

8.  Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans.

Authors:  Laura Calabresi; Damiano Baldassarre; Samuela Castelnuovo; Paola Conca; Letizia Bocchi; Chiara Candini; Beatrice Frigerio; Mauro Amato; Cesare R Sirtori; Paola Alessandrini; Marcello Arca; Giuliano Boscutti; Luigi Cattin; Loreto Gesualdo; Tiziana Sampietro; Gaetano Vaudo; Fabrizio Veglia; Sebastiano Calandra; Guido Franceschini
Journal:  Circulation       Date:  2009-08-18       Impact factor: 29.690

Review 9.  Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis.

Authors:  Matthias Briel; Ignacio Ferreira-Gonzalez; John J You; Paul J Karanicolas; Elie A Akl; Ping Wu; Boris Blechacz; Dirk Bassler; Xinge Wei; Asheer Sharman; Irene Whitt; Suzana Alves da Silva; Zahira Khalid; Alain J Nordmann; Qi Zhou; Stephen D Walter; Noah Vale; Neera Bhatnagar; Christopher O'Regan; Edward J Mills; Heiner C Bucher; Victor M Montori; Gordon H Guyatt
Journal:  BMJ       Date:  2009-02-16

10.  Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants.

Authors:  Sekar Kathiresan; Benjamin F Voight; Shaun Purcell; Kiran Musunuru; Diego Ardissino; Pier M Mannucci; Sonia Anand; James C Engert; Nilesh J Samani; Heribert Schunkert; Jeanette Erdmann; Muredach P Reilly; Daniel J Rader; Thomas Morgan; John A Spertus; Monika Stoll; Domenico Girelli; Pascal P McKeown; Chris C Patterson; David S Siscovick; Christopher J O'Donnell; Roberto Elosua; Leena Peltonen; Veikko Salomaa; Stephen M Schwartz; Olle Melander; David Altshuler; Diego Ardissino; Pier Angelica Merlini; Carlo Berzuini; Luisa Bernardinelli; Flora Peyvandi; Marco Tubaro; Patrizia Celli; Maurizio Ferrario; Raffaela Fetiveau; Nicola Marziliano; Giorgio Casari; Michele Galli; Flavio Ribichini; Marco Rossi; Francesco Bernardi; Pietro Zonzin; Alberto Piazza; Pier M Mannucci; Stephen M Schwartz; David S Siscovick; Jean Yee; Yechiel Friedlander; Roberto Elosua; Jaume Marrugat; Gavin Lucas; Isaac Subirana; Joan Sala; Rafael Ramos; Sekar Kathiresan; James B Meigs; Gordon Williams; David M Nathan; Calum A MacRae; Christopher J O'Donnell; Veikko Salomaa; Aki S Havulinna; Leena Peltonen; Olle Melander; Goran Berglund; Benjamin F Voight; Sekar Kathiresan; Joel N Hirschhorn; Rosanna Asselta; Stefano Duga; Marta Spreafico; Kiran Musunuru; Mark J Daly; Shaun Purcell; Benjamin F Voight; Shaun Purcell; James Nemesh; Joshua M Korn; Steven A McCarroll; Stephen M Schwartz; Jean Yee; Sekar Kathiresan; Gavin Lucas; Isaac Subirana; Roberto Elosua; Aarti Surti; Candace Guiducci; Lauren Gianniny; Daniel Mirel; Melissa Parkin; Noel Burtt; Stacey B Gabriel; Nilesh J Samani; John R Thompson; Peter S Braund; Benjamin J Wright; Anthony J Balmforth; Stephen G Ball; Alistair S Hall; Heribert Schunkert; Jeanette Erdmann; Patrick Linsel-Nitschke; Wolfgang Lieb; Andreas Ziegler; Inke König; Christian Hengstenberg; Marcus Fischer; Klaus Stark; Anika Grosshennig; Michael Preuss; H-Erich Wichmann; Stefan Schreiber; Heribert Schunkert; Nilesh J Samani; Jeanette Erdmann; Willem Ouwehand; Christian Hengstenberg; Panos Deloukas; Michael Scholz; Francois Cambien; Muredach P Reilly; Mingyao Li; Zhen Chen; Robert Wilensky; William Matthai; Atif Qasim; Hakon H Hakonarson; Joe Devaney; Mary-Susan Burnett; Augusto D Pichard; Kenneth M Kent; Lowell Satler; Joseph M Lindsay; Ron Waksman; Christopher W Knouff; Dawn M Waterworth; Max C Walker; Vincent Mooser; Stephen E Epstein; Daniel J Rader; Thomas Scheffold; Klaus Berger; Monika Stoll; Andreas Huge; Domenico Girelli; Nicola Martinelli; Oliviero Olivieri; Roberto Corrocher; Thomas Morgan; John A Spertus; Pascal McKeown; Chris C Patterson; Heribert Schunkert; Erdmann Erdmann; Patrick Linsel-Nitschke; Wolfgang Lieb; Andreas Ziegler; Inke R König; Christian Hengstenberg; Marcus Fischer; Klaus Stark; Anika Grosshennig; Michael Preuss; H-Erich Wichmann; Stefan Schreiber; Hilma Hólm; Gudmar Thorleifsson; Unnur Thorsteinsdottir; Kari Stefansson; James C Engert; Ron Do; Changchun Xie; Sonia Anand; Sekar Kathiresan; Diego Ardissino; Pier M Mannucci; David Siscovick; Christopher J O'Donnell; Nilesh J Samani; Olle Melander; Roberto Elosua; Leena Peltonen; Veikko Salomaa; Stephen M Schwartz; David Altshuler
Journal:  Nat Genet       Date:  2009-02-08       Impact factor: 38.330

View more
  746 in total

Review 1.  Time to ditch HDL-C as a measure of HDL function?

Authors:  Graziella E Ronsein; Jay W Heinecke
Journal:  Curr Opin Lipidol       Date:  2017-10       Impact factor: 4.776

2.  Changes in lipoprotein subfraction concentration and composition in healthy individuals treated with the CETP inhibitor anacetrapib.

Authors:  Ronald M Krauss; Kathleen Wojnooski; Joseph Orr; J Casey Geaney; Cathy Anne Pinto; Yang Liu; John A Wagner; Julie Mabalot Luk; Amy O Johnson-Levonas; Matt S Anderson; Hayes M Dansky
Journal:  J Lipid Res       Date:  2011-12-17       Impact factor: 5.922

3.  Clinical trials of HDL cholesterol-raising therapy: what have we learned about the HDL hypothesis from AIM-HIGH?

Authors:  Robert S Rosenson
Journal:  Curr Atheroscler Rep       Date:  2012-06       Impact factor: 5.113

4.  A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterol.

Authors:  Sandhya Sankaranarayanan; Ginny Kellner-Weibel; Margarita de la Llera-Moya; Michael C Phillips; Bela F Asztalos; Robert Bittman; George H Rothblat
Journal:  J Lipid Res       Date:  2011-09-27       Impact factor: 5.922

5.  LDL-apheresis depletes apoE-HDL and pre-β1-HDL in familial hypercholesterolemia: relevance to atheroprotection.

Authors:  Alexina Orsoni; Samir Saheb; Johannes H M Levels; Geesje Dallinga-Thie; Marielle Atassi; Randa Bittar; Paul Robillard; Eric Bruckert; Anatol Kontush; Alain Carrié; M John Chapman
Journal:  J Lipid Res       Date:  2011-09-26       Impact factor: 5.922

6.  Core hydrophobicity tuning of a self-assembled particle results in efficient lipid reduction and favorable organ distribution.

Authors:  Bhabatosh Banik; Ru Wen; Sean Marrache; Anil Kumar; Nagesh Kolishetti; Elizabeth W Howerth; Shanta Dhar
Journal:  Nanoscale       Date:  2017-12-21       Impact factor: 7.790

7.  Celastrol-loaded PEG-b-PPS nanocarriers as an anti-inflammatory treatment for atherosclerosis.

Authors:  Sean D Allen; Yu-Gang Liu; Taehyeung Kim; Sharan Bobbala; Sijia Yi; Xiaohan Zhang; Jaehyuk Choi; Evan A Scott
Journal:  Biomater Sci       Date:  2019-01-29       Impact factor: 6.843

8.  Cholesteryl ester transfer protein protects against insulin resistance in obese female mice.

Authors:  David A Cappel; Brian T Palmisano; Christopher H Emfinger; Melissa N Martinez; Owen P McGuinness; John M Stafford
Journal:  Mol Metab       Date:  2013-09-02       Impact factor: 7.422

9.  Progression of coronary atherosclerosis in African-American patients.

Authors:  Yu Kataoka; Amy Hsu; Kathy Wolski; Kiyoko Uno; Rishi Puri; E Murat Tuzcu; Steven E Nissen; Stephen J Nicholls
Journal:  Cardiovasc Diagn Ther       Date:  2013-09

10.  Molecular dynamics simulations of lipid nanodiscs.

Authors:  Mohsen Pourmousa; Richard W Pastor
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-05-03       Impact factor: 3.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.